Ankle Joint Injection

Evidence at a Glance

The ankle region resembles the wrist - multiple distinct targets, each with its own code - but the codes differ in an important way. The ankle and subtalar joints are intermediate joints (20605/20606). A tarsal tunnel injection, however, has no dedicated CPT® code and is reported with the unlisted code 28899 (foot or toes) - not the carpal-tunnel code. Plantar fasciitis is reported with 20550 and diagnosis M72.2, and Morton's neuroma uses a nerve-injection code (64455), not a tendon code. Getting the target-to-code mapping right - and handling the unlisted tarsal-tunnel code correctly - is the defining discipline. Hyaluronic acid is not covered for the ankle.

Domain	Summary
Medicare NCD	No national coverage determination specific to ankle injection. Corticosteroid/anesthetic injection is broadly covered when medically necessary.
Medicare LCD / Article	MAC articles address tendon-sheath, ligament, ganglion, and tunnel injections and instruct that tarsal-tunnel injection be reported with 28899 and plantar fasciitis with 20550 (M72.2).
Commercial Coverage	Covered as medically necessary for qualifying ankle/foot pathology, with payer procedure-to-diagnosis lists requiring a supporting diagnosis for each code.
Evidence Level	Moderate short-term benefit for ankle osteoarthritis, plantar fasciitis, and tarsal tunnel syndrome; guidance improves accuracy for deep or small targets.
Image Guidance	Optional. Ultrasound is bundled into 20606 for the joint; for plantar fascia (20550) and other targets, ultrasound is reported separately with 76942 when a permanent image is retained.
Prior Authorization	Generally not required for corticosteroid injection; the unlisted tarsal-tunnel code (28899) is priced by report and may draw manual review. Ankle hyaluronic acid is denied regardless.
Conservative Therapy	Document orthoses/splinting, stretching and physical therapy, activity modification, and analgesics/NSAIDs before injection.
Diagnostic Block	Not typically required. An anesthetic component can localize the pain source within the same encounter.
Key Documentation	The specific target (ankle joint / subtalar / tarsal tunnel / plantar fascia), laterality, guidance modality, injectate and units, and pre-/post pain scores.
Approval Considerations	Target-correct code (including 28899 for tarsal tunnel with the descriptor in Box 19), a supported laterality-specific diagnosis, and documented conservative care.

Procedure Overview

Ankle-region injections deliver corticosteroid and/or anesthetic to one of several structures: the ankle (tibiotalar) joint or subtalar joint for osteoarthritis or inflammatory arthropathy, the tarsal tunnel for posterior tibial nerve compression, the plantar fascia for plantar fasciitis, or a tendon origin/insertion for other tendinopathies. Most targets are accessible by landmark technique, with ultrasound used selectively for deep or small targets and for confirming needle position relative to neurovascular structures.

Operationally, the ankle region maps to a family of codes, and two of them are special cases. Tarsal-tunnel injection has no dedicated code and is reported with the unlisted foot/toes code (28899), which requires a written descriptor and is priced by report. Plantar-fasciitis injection has a specific code-and-diagnosis pairing (20550 with M72.2). The controlling discipline is documenting the exact structure and handling these special cases correctly rather than defaulting to the joint code.

Relevant Anatomy (High-Level)

The relevant structures are the tibiotalar (ankle) and subtalar joints, the tarsal tunnel (through which the posterior tibial nerve passes behind the medial malleolus), the plantar fascia (aponeurosis on the sole), and the major foot/ankle tendons (Achilles, posterior tibial). Each is a distinct target with a distinct code. The key coding facts are that the tarsal tunnel is a nerve tunnel without a dedicated CPT® injection code, and the plantar fascia is an aponeurosis reported with the tendon-sheath code - neither is "the ankle joint."

Clinical Indications

Ankle (tibiotalar) or subtalar osteoarthritis or inflammatory arthropathy with intra-articular pain, or symptomatic effusion requiring aspiration.
Tarsal tunnel syndrome with posterior tibial nerve symptoms.
Plantar fasciitis refractory to conservative care.
Other foot/ankle tendinopathy at a tendon origin/insertion (for example calcaneal spur).
Symptoms persisting despite documented conservative care.

Patient Selection

Selection depends on localizing the pain generator so the correct target is injected and coded:

Examination and, where indicated, imaging or electrodiagnostic findings localizing the pathology.
A documented trial of, or contraindication to, conservative management including orthoses and stretching.
Functional impairment the injection is intended to improve (weight-bearing, gait, first-step pain).
Caution and realistic expectations for injections near weight-bearing tendons (for example avoidance of intratendinous Achilles corticosteroid given rupture risk).
Aspiration considered where a symptomatic effusion is present.

Contraindications

Absolute	Relative
Overlying infection; suspected septic joint.	Therapeutic anticoagulation or coagulopathy (individualized).
Known allergy to the planned injectate.	Poorly controlled diabetes (corticosteroid glycemic effect; foot-care risk).
Patient refusal or inability to cooperate.	Intratendinous Achilles injection (rupture risk) - generally avoided.

Peripheral vascular disease or neuropathy affecting the foot.

Medical Necessity

Medical necessity is established by documenting the pain generator, the failure of conservative care, and the therapeutic goal. Payers expect:

The specific target and a supported diagnosis consistent with it (for example tarsal tunnel syndrome for a tarsal-tunnel injection).
Laterality of the affected ankle/foot.
A documented conservative-care trial and outcome, or a contraindication (orthoses and stretching are commonly expected for plantar fasciitis and tarsal tunnel).
The functional deficit treated and the therapeutic goal.
For an unlisted-code service (28899), a written descriptor and rationale supporting the by-report pricing.

Medicare Coverage Guidance

No National Coverage Determination is specific to ankle injection, but MACs publish articles addressing tendon-sheath, ligament, ganglion, and tunnel injections. Key principles:

Joint codes. Ankle and subtalar joints are intermediate (20605/20606).
Tarsal tunnel. Report 28899 (unlisted, foot or toes) with "tarsal tunnel syndrome" in Box 19; there is no specific CPT® code.
Plantar fasciitis. Report 20550 with diagnosis M72.2; calcaneal-spur injections are reported as tendon origin/insertion (20551), and a combined plantar-fascia-plus-spur injection is a single 20551.
Morton's neuroma. Report 64455 (or 64632), not a tendon code; this is a forefoot nerve target, not an ankle structure.
Supported diagnoses. Each code has a supported-diagnosis list (for example G57.5- tarsal tunnel codes); codes outside the list are denied.
Single unit; guidance. One unit per site; ultrasound is bundled into 20606 for the joint but reported separately (76942) for other targets with a retained image.

Commercial Payer Comparison

Payer / Program	Typical Posture on Ankle/Foot Injection
eviCore / Carelon / Cohere / Evolent	Corticosteroid joint, tendon, and tunnel injections generally not managed by interventional-pain UM programs; verify any delegation.
Cigna	Covered for qualifying ankle/foot pathology refractory to conservative care; viscosupplementation restricted to the knee.
Aetna	Considers corticosteroid ankle/foot injection medically necessary for documented pathology; certain regenerative injectates considered experimental.
UnitedHealthcare	Maintains a procedure-to-diagnosis policy for tendon-sheath, ligament, ganglion, and tunnel injections; reimburses only with a supporting diagnosis on the claim.
Humana	Medicare Advantage aligns with CMS/MAC principles; commercial follows medical-necessity criteria with frequency edits.
Blue Cross Blue Shield plans	Plan-specific policies; corticosteroid injection covered for qualifying pathology; ankle viscosupplementation non-covered. Verify the local licensee policy.
By-Report Codes Need a By-Rep Because tarsal-tunnel injection use manually. Submit a clear operative analogous listed code to support pr	ort Package s an unlisted code (28899), commercial payers price it by report and often review it note, the "tarsal tunnel syndrome" descriptor, and, where helpful, a comparison to an icing. A bare unlisted-code claim invites delay or denial.

Documentation Requirements

Specific target (ankle joint / subtalar / tarsal tunnel / plantar fascia / tendon).
Laterality (right / left) documented.
Supported diagnosis consistent with the target.
Conservative therapy history and outcome.
Guidance modality (landmark / ultrasound).
For non-joint targets with ultrasound: retained image for 76942.
For tarsal tunnel: descriptor in Box 19 and by-report note.
Injectate name, concentration, and units.
Pre-injection numeric pain score.
Post-injection pain score and immediate percent relief.
Functional impairment and therapeutic goal.
Signed and dated procedure note.

Imaging Requirements

Diagnostic evaluation may include radiographs (ankle/subtalar osteoarthritis, calcaneal spur), ultrasound (plantar fascia thickening, tenosynovitis), MRI where indicated, and electrodiagnostic studies for tarsal tunnel syndrome. Procedural guidance is optional and target-dependent. For the ankle or subtalar joint, ultrasound guidance is bundled into 20606. For the plantar fascia (20550), the tarsal tunnel (28899), and other non-joint targets, ultrasound guidance is reported separately with 76942 when a permanent image is retained. Ultrasound is particularly useful for confirming plantar-fascia and tarsal-tunnel needle placement and for avoiding neurovascular structures.

Prior Authorization Workflow

Benefit verification. Confirm coverage for the specific injection and the payer's diagnosis-to-procedure requirements; confirm ankle hyaluronic acid is non-covered before offering it.
Target identification. Determine and document the specific structure before the encounter where possible.
Diagnosis validation. Confirm a supported, laterality-specific diagnosis for the chosen code (for example G57.5- for tarsal tunnel; M72.2 for plantar fasciitis).
Unlisted-code preparation. For tarsal tunnel, prepare the 28899 by-report package (descriptor, note, comparison code).
Conservative-care confirmation. Verify the documented trial satisfies the payer's expectation.
Guidance decision. Map guidance to reporting (bundled 20606 for the joint; separate 76942 for other targets).
Procedure and coding. Select the correct code; one unit per site; apply modifiers per code rules.

Common Prior Authorization & Claim Denials

Denial Reason	Root Cause / Prevention
Tarsal tunnel coded as carpal tunnel or joint	20526 or 20605 billed for tarsal tunnel. Report 28899 with the descriptor in Box 19.
Unlisted code without a by-report package	28899 billed with no descriptor or note. Provide the operative note, descriptor, and comparison code.
Plantar fasciitis mis-coded	Reported as a joint or wrong tendon code. Report 20550 with M72.2 (single 20551 if combined with a calcaneal spur).
Morton's neuroma mis-coded	Billed with 20550/20551. Report 64455 (or 64632); it is a nerve target, not a tendon.
Diagnosis not supported for the code	Code billed without a matching supported diagnosis. Pair each code with its supported diagnosis (for example G57.5- for tarsal tunnel).
Guidance mis-reported	76942 added to a joint injection (bundled in 20606), or omitted for a non-joint target where used. Map guidance to the target.
Ankle hyaluronic acid billed	Viscosupplementation is knee-only. Do not bill ankle HA; drug and injection deny.
Multiple units for one site	More than one unit for the same site/encounter. Report a single unit per site.

Appeal Strategies

Submit the procedure note documenting the specific target, laterality, guidance modality, injectate and units, and pre-/post pain scores.
For tarsal-tunnel denials, supply the 28899 by-report package with the descriptor and a comparison code supporting pricing.
For plantar-fasciitis denials, confirm 20550 with M72.2 and resubmit if mis-coded.
For diagnosis denials, correct to a supported, laterality-specific code for the code billed.
For guidance denials, supply the retained ultrasound image (for 76942) and the rationale.
Do not appeal ankle hyaluronic-acid denials on medical-necessity grounds; the non-coverage is categorical.

Coding & Billing Overview

Applicable CPT® Codes by Target

CPT®	Descriptor / Target	Application
20605 / 20606	Intermediate joint or bursa (without / with ultrasound)	Ankle (tibiotalar) and subtalar joints.
28899	Unlisted procedure, foot or toes	Tarsal tunnel injection (no dedicated code; descriptor in Box 19).
20550	Injection(s); single tendon sheath, ligament, aponeurosis (e.g., plantar "fascia")	Plantar fasciitis.
20551	Injection(s); single tendon origin/insertion	Calcaneal spur / other tendon origin/insertion; plantar fascia plus spur = single 20551.
64455	Injection, plantar common digital nerve (e.g., Morton's neuroma)	Morton's neuroma (forefoot; not an ankle structure).

HCPCS (Injectate)

Corticosteroid is reported with the appropriate J-code (for example J1030 methylprednisolone acetate 40 mg, or J3301 triamcinolone acetonide per 10 mg) on the same claim. Local anesthetics are frequently not separately payable. Hyaluronic acid supply codes apply to the knee only and should not be reported for the ankle.

Common ICD-10-CM Diagnosis Codes

Code	Description	Paired Code / Target
M19.071 / M19.072	Primary osteoarthritis, right / left ankle and foot	20605/20606 (ankle/subtalar).
G57.51 / G57.52 / G57.53	Tarsal tunnel syndrome, right / left / bilateral	28899 (tarsal tunnel).
M72.2	Plantar fascial fibromatosis (plantar fasciitis)	20550 (plantar fascia).
M76.61 / M76.62	Achilles tendinitis, right / left leg	20551 (tendon; caution re Achilles).
G57.61 / G57.62	Lesion of plantar nerve (Morton's), right / left	64455 (Morton's neuroma).
M25.571 / M25.572	Pain in right / left ankle and joints of foot	When specific diagnosis not established.

Modifiers, POS & ASC

Element	Guidance
Modifier 50	May be used with 20550 for bilateral; not with 20551 or 20612. For 28899 and joint codes, follow carrier/RT-LT rules.
Modifier RT / LT	Identify the ankle/foot; required where modifier 50 is not used.
Modifier 59 / X{EPSU}	For a genuinely distinct additional structure, with documentation.
Modifier 25	For a significant, separately identifiable E/M on the same day.
Place of Service	POS 11 (office) typical; POS 22 or 24 where applicable.
ASC considerations	Predominantly office-based; ASC use is uncommon.

Clinical Documentation Checklist

Specific target documented.
Laterality (RT / LT).
Supported diagnosis matched to code.
Conservative therapy trial and outcome.
Guidance modality and (for non-joint targets) image retained.

For tarsal tunnel: descriptor in Box 19 and by-report note.
Injectate name, concentration, units.
Pre-injection numeric pain score.
Post-injection pain score and percent relief.
Correct code selected (joint / 28899 / 20550 / 20551 / 64455).
No ankle hyaluronic acid billed.
Functional goal documented.

Procedure Comparison

Target	CPT®	Diagnosis	Notes
Ankle / subtalar joint	20605 / 20606	M19.07-	Intermediate joint.
Tarsal tunnel	28899 (unlisted)	G57.5-	By report; descriptor in Box 19.
Plantar fascia	20550	M72.2	Aponeurosis; specific pairing.
Calcaneal spur / tendon	20551	Tendon dx	Single 20551 if with plantar fascia.
Morton's neuroma	64455	G57.6-	Nerve target; not a tendon code.

GoHealthcare Clinical Insights

Do not let the wrist analogy mislead the code. The tarsal tunnel is the clinical cousin of the carpal tunnel, but it uses the unlisted code 28899, not 20526. A note template that forces target selection - and a coding rule that routes tarsal tunnel to 28899 with the Box-19 descriptor - prevents the most consequential ankle error. Prepare the unlisted-code package up front. Because 28899 is priced by report and reviewed manually, assemble the operative note, descriptor, and a comparison code before submission so the claim is not delayed or denied for lack of support. Lock in the plantar-fascia pairing. Plantar fasciitis is 20550 with M72.2 - a specific, well-established pairing. Encoding it prevents the common mis-code to a joint or wrong tendon code.

GoHealthcare Leadership Perspective

The ankle closes this series with a familiar lesson and a new wrinkle. Like the wrist, it is a region of multiple distinct codes; unlike the wrist, one of its most common targets - the tarsal tunnel - has no dedicated code and must be handled as an unlisted, by-report service. Practices that treat it as a joint or borrow the carpal-tunnel code generate predictable denials. The leadership priorities are a target-selection template, a coding rule set that routes each target to its correct code (including 28899 for tarsal tunnel with the Box-19 descriptor and 64455 for Morton's neuroma), an unlisted-code by-report workflow, and a diagnosis-to-code check tied to payer procedure-to-diagnosis policies. These controls close the region cleanly.

GoHealthcare Prior Authorization Insight

The authorization insight for the ankle is that the unlisted tarsal-tunnel code is the exposure. It is rarely prior-authorized, but it is priced by report and manually reviewed, so an incomplete submission is functionally a denial. The remaining targets deny for the same target-coding and diagnosis-pairing reasons seen across this series. Our quality-assurance approach verifies target-to-code alignment (including correct use of 28899 and 64455), diagnosis-to-code support, and the unlisted-code by-report package before the claim drops, and excludes ankle hyaluronic acid categorically. This front-loads the documentation the payer will otherwise demand on review.

GoHealthcare Case Study

The following case is a composite created for education. It does not depict any actual patient or organization.

Clinical Scenario

A patient with tarsal tunnel syndrome, refractory to orthoses and NSAIDs, underwent a corticosteroid injection of the tarsal tunnel. The practice billed 20526 (the carpal-tunnel code) with a generic foot-pain diagnosis.

Documentation & Coding Challenges

The claim denied. Tarsal-tunnel injection has no dedicated code and should have been reported with the unlisted foot/toes code 28899, with "tarsal tunnel syndrome" in Box 19 and a by-report note; the carpal-tunnel code 20526 does not apply to the foot; and the diagnosis should have been a tarsal tunnel syndrome code (G57.5-) rather than generic foot pain.

Payer & Prior Authorization Barriers

No prior authorization was required, but the unlisted service required a by-report package that had not been prepared, and no checkpoint had validated the target-to-code alignment before submission.

Resolution Strategy

The practice recoded to 28899 with the descriptor and operative note, corrected the diagnosis to tarsal tunnel syndrome with laterality, and resubmitted with a comparison code to support pricing. Prospectively, it added a coding rule routing tarsal tunnel to 28899 and an unlisted-code by-report workflow.

Outcome & Lessons Learned

The corrected claim was paid, and ankle/foot injection denials fell in the following quarter. The lesson: the tarsal tunnel must be handled as an unlisted, by-report service, and each ankle/foot target routed to its correct code - controls that operate independently of any authorization requirement.

GoHealthcare Best Practices

Require target selection (ankle joint / subtalar / tarsal tunnel / plantar fascia / tendon) in the note template.
Route tarsal tunnel to 28899 with the Box-19 descriptor and a by-report package; route Morton's neuroma to 64455.
Encode the plantar-fasciitis pairing (20550 with M72.2).
Pair each code with a supported, laterality-specific diagnosis before the claim drops.
Apply the correct guidance reporting (bundled 20606; separate 76942 for non-joint targets).
Block ankle hyaluronic acid at the claim-edit level.

Common Mistakes

Coding tarsal-tunnel injection as carpal tunnel (20526) or as the ankle joint.
Billing the unlisted code 28899 without a descriptor or by-report note.
Mis-coding plantar fasciitis to a joint or wrong tendon code instead of 20550 (M72.2).
Mis-coding Morton's neuroma with a tendon code instead of 64455.
Reporting a code without a supported, matching diagnosis.
Adding 76942 to a joint injection (guidance is bundled in 20606).
Billing ankle hyaluronic acid, which is non-covered.
Injecting corticosteroid intratendinously into the Achilles (rupture risk).

Pearls and Pitfalls

Pearls	Pitfalls
Route tarsal tunnel to 28899 with a by-report package.	Borrowing the carpal-tunnel code 20526 for the foot.
Encode the plantar-fasciitis pairing (20550 / M72.2).	Mis-coding plantar fasciitis to a joint code.
Route Morton's neuroma to 64455.	Billing Morton's neuroma with a tendon code.
Pair each diagnosis to its code.	Reporting a code with an unsupported diagnosis.
Avoid intratendinous Achilles corticosteroid.	Injecting the Achilles tendon and risking rupture.

Frequently Asked Questions

What code is used for an ankle (tibiotalar) joint injection?

20605 (without ultrasound) or 20606 (with ultrasound). The ankle is an intermediate joint; the subtalar joint uses the same codes.

What code is used for a tarsal-tunnel injection?

28899 (Unlisted procedure, foot or toes), because there is no dedicated CPT® code. Place "tarsal tunnel syndrome" in Box 19 and submit a by-report note.

Can I use the carpal-tunnel code (20526) for the tarsal tunnel?

No. 20526 is specific to the carpal tunnel. The tarsal tunnel has no dedicated code and is reported with 28899.

What code is used for a plantar-fasciitis injection?

20550 (single tendon sheath/aponeurosis, with plantar fascia as the example), paired with diagnosis M72.2.

How is a calcaneal-spur injection coded?

As a tendon origin/insertion (20551). A combined plantar-fascia-plus-spur injection is reported with a single 20551.

How is a Morton's-neuroma injection coded?

64455 (or 64632 for destruction). It is a plantar digital nerve target, not a tendon; do not use 20550/20551.

What diagnosis supports a tarsal-tunnel injection?

Tarsal tunnel syndrome codes: G57.51 (right), G57.52 (left), G57.53 (bilateral), or G57.50 (unspecified).

What diagnosis is used for plantar fasciitis?

M72.2 (plantar fascial fibromatosis), paired with 20550.

How do I report ultrasound guidance at the ankle/foot?

For the ankle or subtalar joint, ultrasound is bundled into 20606. For plantar fascia and other non-joint targets, report ultrasound separately with 76942 when a permanent image is retained.

Is hyaluronic acid covered for the ankle?

No. Hyaluronic acid is covered for the knee only; ankle viscosupplementation is non-covered.

Why does an unlisted code require special handling?

28899 is priced by report and often reviewed manually, so a descriptor, operative note, and comparison code are needed to support the claim.

How many units per site?

One. Multiple injections at the same site on the same day are one injection, reported as one unit.

Can I inject the Achilles tendon with corticosteroid?

Intratendinous Achilles corticosteroid is generally avoided due to rupture risk; document the assessment and any peritendinous approach used.

Does ankle injection require prior authorization?

Corticosteroid injection usually does not, though the unlisted tarsal-tunnel code may draw manual review. Ankle hyaluronic acid is non-covered regardless.

Is conservative care required first?

Frequently, especially orthoses and stretching for plantar fasciitis and tarsal tunnel. Document the trial and outcome.

What place of service applies?

POS 11 (office) is typical; POS 22 or 24 where applicable.

Which ankle codes can take modifier 50?

Modifier 50 may be used with 20550 for bilateral, but not with 20551 or 20612; for 28899 and joint codes, follow carrier and RT/LT rules.

Does tarsal tunnel syndrome have a bilateral diagnosis code?

Yes, G57.53. Use it when bilateral tarsal tunnel syndrome is documented.

Can I aspirate and inject the ankle joint in one session?

Yes; report a single unit of 20605/20606 for the combined aspiration and injection of that joint.

What single control most reduces ankle/foot injection denials?

A target-selection field routing each structure to its correct code, including 28899 for tarsal tunnel and 64455 for Morton's neuroma.

Can I bill an E/M on the same day?

Only for a significant, separately identifiable evaluation beyond the injection work, with modifier 25.

Why did my ankle/foot claim deny?

Common causes are tarsal-tunnel mis-coding, a bare unlisted-code claim, plantar-fasciitis mis-coding, or an unsupported diagnosis. Correct and resubmit.

Key Takeaways

Ankle and subtalar joints are intermediate (20605/20606).
Tarsal-tunnel injection uses the unlisted code 28899 (not the carpal-tunnel code), with the descriptor in Box 19 and a by-report package.
Plantar fasciitis is 20550 with M72.2; calcaneal spur (and combined) is 20551.
Morton's neuroma is 64455 (or 64632), not a tendon code.
Pair each code with a supported, laterality-specific diagnosis (G57.5- has a bilateral code, G57.53).
Ultrasound is bundled into 20606 for the joint but reported separately (76942) for non-joint targets.
Hyaluronic acid is not covered for the ankle; avoid intratendinous Achilles corticosteroid.

Future Outlook

Ultrasound will continue to expand for ankle and foot injections, improving accuracy for the plantar fascia and tarsal tunnel and reinforcing correct, target-specific guidance reporting. A dedicated CPT® code for tarsal-tunnel injection may eventually replace the unlisted 28899; until then, disciplined by-report handling remains essential. Payer procedure-to-diagnosis enforcement is likely to tighten, making diagnosis-to-code pairing increasingly decisive. Corticosteroid ankle/foot injection will remain a covered, commonly performed service, while ankle viscosupplementation remains non-covered. Practices that adopt a code-family approach now will adapt smoothly as edits and codes evolve.

References

American Medical Association. CPT® 2026 Professional Edition (20550, 20551, 20605, 20606, 20612, 28899, 64455). https://www.ama-assn.org/practice-management/cpt Centers for Medicare & Medicaid Services. Billing and Coding: Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma (A57079) - 28899 for tarsal tunnel; 20550/M72.2 for plantar fasciitis; 64455 for Morton's neuroma. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=57079 Centers for Medicare & Medicaid Services. Billing and Coding Guidelines for Injections (tarsal tunnel descriptor in Item 19). https://www.cms.gov/medicare-coverage-database ICD-10-CM 2026, G57.5- (Tarsal tunnel syndrome), M72.2 (Plantar fascial fibromatosis), M19.07- (Primary OA of ankle and foot), G57.6- (Lesion of plantar nerve). https://www.icd10data.com/ICD10CM/Codes UnitedHealthcare. Injections into Tendon Sheath, Ligament, Ganglion Cyst, Carpal/Tarsal Tunnel - procedure-to-diagnosis policy. https:// www.uhcprovider.com/content/dam/provider/docs/public/policies/medicaid-comm-plan-reimbursement/UHCCP-Injections-Tendon-Sheath-L igament-Ganglion-Cyst-Carpal-Tarsal-Tunnel-Policy.pdf American Orthopaedic Foot & Ankle Society (AOFAS). https://www.aofas.org American Academy of Orthopaedic Surgeons (AAOS). https://www.aaos.org

Reading Recommendations

AMA CPT® guidance on joint, tendon, and unlisted foot/toes injection codes.
Your MAC's tendon/ganglion/tunnel injection article, including the tarsal-tunnel and plantar-fasciitis instructions.
Payer procedure-to-diagnosis policies and unlisted-code (by-report) submission requirements.
AOFAS and AAOS guidance on ankle osteoarthritis, plantar fasciitis, and tarsal tunnel syndrome.

Recommended Downloads

Ankle/Foot Injection Structured Note Template (with required target field).
Target-to-Code Quick-Reference (joint / tarsal tunnel / plantar fascia / tendon / Morton's neuroma).
Unlisted-Code (28899) By-Report Submission Checklist.
Diagnosis-to-Code Pairing Worksheet (procedure-to-diagnosis compliance).

Visual Recommendations

High-level illustration of ankle/foot injection targets (ankle and subtalar joints, tarsal tunnel, plantar fascia).
Target-to-code decision tree, including the unlisted tarsal-tunnel path.
Unlisted-code by-report submission workflow.
Diagnosis-to-code pairing matrix.
Guidance-reporting decision flow (bundled vs separate).
Documentation checklist infographic for point-of-care use.

Educational Disclaimer

This document is intended for educational and operational reference purposes only. It does not replace physician clinical judgment, payer policy review, legal advice, or official CMS guidance, and it is not a procedural or physician training manual. Coverage policies, coding guidance, frequency limitations, and reimbursement requirements change frequently and vary by payer, plan, and jurisdiction; all codes and coverage criteria must be independently verified against the applicable payer policy and current regulatory sources before submission. CPT® is a registered trademark of the American Medical Association. GoHealthcare Practice Solutions assumes no liability for actions taken in reliance on this educational material.

This webpage does not replace physician judgment, official payer policy, legal advice, or current coding guidance. CPT® is a registered trademark of the American Medical Association.